Log in

Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1

References

  1. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20(4):695–704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Martino P, Gastaldi R, Raccah R, Girmenia C (1994) Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 28(Suppl 1):7–15

    Article  PubMed  Google Scholar 

  3. Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, Paripovic L, Klingspor L, Nordøy I, Hamal P, Arikan Akdagli S, Ossi C, Grancini A, Cavanna C, Lo Cascio G, Scarparo C, Candoni A, Caira M, Drogari Apiranthitou M, ECMM Working Group (2014) European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 33(9):1623–1630

    Article  CAS  PubMed  Google Scholar 

  4. Wang ML, Blum KA, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, Williams ME, Barrientos JC, Chmielowska E, Radford J, Stilgenbauer S, Dreyling M, Jedrzejczak WW, Johnson P, Spurgeon SE, Zhang L, Baher L, Cheng M, Lee D, Beaupre DM, Rule S (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126(6):739–745

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Okamoto K, Proia LA, Demarais PL (2016) Disseminated cryptococcal disease in a patient with chronic lymphocytic leukemia on ibrutinib. Case Rep Infect Dis 2016:4642831

    PubMed  PubMed Central  Google Scholar 

  6. Ahn IE, Jerussi T, Farooqui M, Tian X, Wiestner A, Gea-Banacloche J (2016) Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib. Blood 128(15):1940–1943

    Article  CAS  PubMed  Google Scholar 

  7. Kanegane H, Nakano T, Shimono Y, Zhao M, Miyawaki T (2009) Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia. Int J Hematol 89(5):716–717

    Article  PubMed  Google Scholar 

  8. Martin-Garrido I, Carmona EM, Specks U, Limper AH (2013) Pneumocystis pneumonia in patients treated with rituximab. Chest 144(1):258–265

    Article  CAS  PubMed  Google Scholar 

  9. Tse E, Leung RY, Kwong YL (2015) Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia. Ann Hematol 94(1):165–167

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yok-Lam Kwong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan, T.S.Y., Au-Yeung, R., Chim, CS. et al. Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia. Ann Hematol 96, 871–872 (2017). https://doi.org/10.1007/s00277-017-2944-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-2944-7

Keywords

Navigation